Cost-effectiveness of molar single-implant versus fixed dental prosthesis
- PMID: 30126400
- PMCID: PMC6102921
- DOI: 10.1186/s12903-018-0604-5
Cost-effectiveness of molar single-implant versus fixed dental prosthesis
Abstract
Background: This study evaluates the cost-effectiveness of implants (Implant), insurance fixed dental prosthesis (IFDP) and private fixed dental prosthesis (PFDP) for a single intermediate missing tooth in the molar region to calculate the Incremental Cost Effectiveness Ratio (ICER).
Methods: The Markov model for cost-effectiveness analysis of the Implant, IFDP and PFDP was carried over maximum 30 years. The starting age for prosthetic treatment was decided to be 50 years. The General Oral Health Assessment Index (GOHAI) was used for the indicator of effectiveness as an oral health QOL value. The GOHAI value was collected from patients who visited the Department of Oral Implantology of Osaka Dental University between September 2014 and March 2016. In addition, the Tornado diagram was drawn and Monte-Carlo simulations made for sensitivity analysis.
Results: From the analysis of survey of QOL of each stage and treatment, the selection of an Implant led to a higher QOL value than FDP. However, the estimated 30-year cost for IFDP was lower than Implant. It also became evident that PFDP had an extended dominated condition compared with IFDP and Implants. The ICER on the Implant versus IFDP was €1423.00.
Conclusions: These results suggest that a better of QOL value can be obtained from an Implant than from IFDP or PFDP. An evaluation form using an indexed scale for oral health-related aspects needs to be developed that is also consistent as an indicator of effect.
Keywords: Cost-effectiveness analysis; Dental implant; Economic evaluative; Markov model; Patient reported outcome.
Conflict of interest statement
Ethics approval and consent to participate
The study obtained the approval (E2536) of the Ethics Committee of Kyoto University. Written informed consent was obtained from the participants that were included in this study.
Consent for publication
Not application.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
-
- MIGA column. https://www.meiji.ac.jp/miga/6t5h7p00000ec1v4-att/20141009profkamae_1.pdf. Accessed 23 Oct 2016.
-
- Kamae I. Perspective on Pharmacoeconomic approaches to health technology assessment<1>-recent development in assessing innovation-. Pharmaceutical and Medical Device Regulatory Science. 2012;43(1):39–44.
-
- Kamae I. Perspective on Pharmacoeconomic approaches to health technology assessment<4>−a key to proper interpretation of the QALY and the ICER-. Pharm Med Device Regulatory Sci. 2012;43(8):686–92.
-
- The situation of the dental treatment. http://www.mhlw.go.jp/toukei/saikin/hw/sinryo/tyosa14/dl/sika.pdf. Accessed 23 Oct 2016.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources